Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Citizen Meds vs TeleClinic

Citizen Meds
Graded #245

Higher grade

vs+3.200000000000003
TeleClinic
Graded #313

Lower grade

The verdict

Citizen Meds takes it — 64/100 to 60.8/100.

Citizen Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Citizen Meds is a GLP-1/weight-loss injection provider offering semaglutide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCitizen Meds +27
71
44
Dose & formulationTeleClinic +10
54
64
Clinical oversightTeleClinic +1
79
80
Labs & monitoringEven
52
52
FulfillmentTeleClinic +35
62
97
Contract termsCitizen Meds +35
55
20
Citizen Meds · left barTeleClinic · right bar

The numbers

MetricCitizen MedsTeleClinic
WeighScore64/10060.8/100
GradeCC
Scorecard rank#245#313
Semaglutide$125/mo (0.25 mg dose, compounded)$199/mo (compounded)
Tirzepatide$185/mo (2.5 mg dose, first-month rate, compounded)$299/mo (compounded)
CoverageCoverage not published47 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Citizen Meds

Graded #245 · C

Strengths

  • Semaglutide confirmed from product listings
  • New-patient discount available (code NEWPATIENT10)

Where it loses points

  • No visible LegitScript or PCAB accreditation
  • State availability not disclosed
  • About page returns a 404
  • Limited overall transparency
TeleClinic

Graded #313 · C

Strengths

  • Names its pharmacy partner — Rush Pharmacy, a licensed 503A compounder — which many compounded-GLP-1 telehealths won't disclose
  • LegitScript certified with flat, published monthly pricing, free shipping, and no insurance required
  • Broad access: 47 states with US-licensed physicians and transparent cash-pay pricing

Where it loses points

  • Compounded semaglutide and tirzepatide only — no brand-name GLP-1 (Wegovy or Zepbound) option
  • Headline $139/$219 rates are first-quarter intro prices billed quarterly; ongoing month-to-month is $199/$299
  • Not available in California, South Carolina, or New Jersey

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard